MIM
Martin Investment Management Portfolio holdings
AUM
$390M
This Quarter Return
+8.71%
1 Year Return
+9.2%
3 Year Return
+57.18%
5 Year Return
+97.51%
10 Year Return
+265.79%
AUM
$460M
AUM Growth
+$460M
(+8.9%)
Cap. Flow
+$2.77M
Cap. Flow
% of AUM
0.6%
Top 10 Holdings %
Top 10 Hldgs %
41.82%
Holding
47
New
–
Increased
24
Reduced
18
Closed
–
Top Buys
| 1 |
Abbott
ABT
|
$2.22M |
| 2 |
Oracle
ORCL
|
$1.01M |
| 3 |
NOV
NOV
|
$998K |
| 4 |
Exxon Mobil
XOM
|
$747K |
| 5 |
Accenture
ACN
|
$481K |
Top Sells
| 1 |
CELG
Celgene Corp
CELG
|
$1.53M |
| 2 |
Mastercard
MA
|
$1.09M |
| 3 |
Thermo Fisher Scientific
TMO
|
$565K |
| 4 |
Johnson & Johnson
JNJ
|
$316K |
| 5 |
VAR
Varian Medical Systems, Inc.
VAR
|
$249K |
Sector Composition
| 1 | Healthcare | 23.72% |
| 2 | Technology | 16.31% |
| 3 | Energy | 16.23% |
| 4 | Financials | 12.85% |
| 5 | Industrials | 10.39% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
1
Mastercard
MA
$538B
| $23.8M | 5.17% |
35,402
-1,625
| -4% | -$1.09M |
|
2
Apple
AAPL
$3.45T
| $23.5M | 5.1% |
49,284
+72
| +0.1% | +$34.3K |
|
|
CELG
3
DELISTED
Celgene Corp
CELG
| $21.9M | 4.75% |
142,113
-9,942
| -7% | -$1.53M |
|
4
Gilead Sciences
GILD
$140B
| $19.1M | 4.15% |
303,784
+144
| +0% | +$9.05K |
|
|
5
Thermo Fisher Scientific
TMO
$186B
| $18.1M | 3.93% |
196,532
-6,132
| -3% | -$565K |
|
6
Berkshire Hathaway Class B
BRK.B
$1.09T
| $18.1M | 3.92% |
159,068
+721
| +0.5% | +$81.8K |
|
|
7
Oracle
ORCL
$635B
| $17.2M | 3.73% |
517,615
+30,525
| +6% | +$1.01M |
|
|
8
NOV
NOV
$4.94B
| $17.2M | 3.73% |
219,621
+12,772
| +6% | +$998K |
|
9
Fiserv
FI
$75.1B
| $17.1M | 3.72% |
169,552
-1,399
| -0.8% | -$141K |
|
10
3M
MMM
$82.8B
| $16.6M | 3.61% |
139,162
-1,148
| -0.8% | -$137K |
|
11
Helmerich & Payne
HP
$2.08B
| $16.6M | 3.6% |
240,659
-1,487
| -0.6% | -$103K |
|
12
Alphabet (Google) Class C
GOOG
$2.58T
| $16.6M | 3.6% |
18,902
-193
| -1% | -$169K |
|
13
Omnicom Group
OMC
$15.2B
| $16.3M | 3.54% |
257,170
+289
| +0.1% | +$18.3K |
|
|
14
Johnson & Johnson
JNJ
$427B
| $15.9M | 3.46% |
183,762
-3,642
| -2% | -$316K |
|
|
VAR
15
DELISTED
Varian Medical Systems, Inc.
VAR
| $15.9M | 3.46% |
212,996
-3,334
| -2% | -$249K |
|
16
RTX Corp
RTX
$212B
| $15.8M | 3.43% |
146,522
-317
| -0.2% | -$34.2K |
|
17
Stryker
SYK
$150B
| $15.4M | 3.34% |
227,604
-2,876
| -1% | -$194K |
|
18
American Express
AXP
$231B
| $14.9M | 3.23% |
197,005
+1,315
| +0.7% | +$99.3K |
|
19
Colgate-Palmolive
CL
$67.9B
| $14.8M | 3.22% |
249,750
-85
| -0% | -$5.04K |
|
20
Procter & Gamble
PG
$368B
| $14.6M | 3.17% |
192,938
+561
| +0.3% | +$42.4K |
|
21
Verisk Analytics
VRSK
$37.5B
| $14.2M | 3.08% |
218,549
-1,871
| -0.8% | -$122K |
|
|
22
Exxon Mobil
XOM
$487B
| $14.1M | 3.05% |
163,382
+8,682
| +6% | +$747K |
|
23
Chevron
CVX
$324B
| $14M | 3.03% |
114,930
-24
| -0% | -$2.92K |
|
|
24
Abbott
ABT
$231B
| $9.86M | 2.14% |
297,071
+67,027
| +29% | +$2.22M |
|
25
IBM
IBM
$227B
| $9.38M | 2.04% |
50,645
-715
| -1% | -$132K |
|